Editorial
doi: 10.1136/annrheumdis-2017-212588.
Epub 2018 Feb 19.
Pneumocystis and glucocorticoid use: to prophylax or not to prophylax (and when?); that is the question
Affiliations
- PMID: 29459427
- DOI: 10.1136/annrheumdis-2017-212588
Item in Clipboard
Editorial
Pneumocystis and glucocorticoid use: to prophylax or not to prophylax (and when?); that is the question
Ann Rheum Dis.
2018 May.
No abstract available
Keywords: corticosteroids; infections; rheumatoid arthritis.
Conflict of interest statement
Competing interests: KLW has been a consultant and/or investigator for Pfizer, AbbVie, Lilly, BMS, Galapagos and UCB. JWB has been a consultant for Pfizer, Merck and R-Pharm.
Comment on
-
Prophylactic effect of trimethoprim-sulfamethoxazole for pneumocystis pneumonia in patients with rheumatic diseases exposed to prolonged high-dose glucocorticoids.Ann Rheum Dis. 2018 May;77(5):644-649. doi: 10.1136/annrheumdis-2017-211796. Epub 2017 Nov 1. Ann Rheum Dis. 2018. PMID: 29092853 Free PMC article.
Similar articles
-
Predictive factors of pneumocystis pneumonia in patients with rheumatic diseases exposed to prolonged high-dose glucocorticoids.Ann Rheum Dis. 2020 Feb;79(2):e23. doi: 10.1136/annrheumdis-2018-214718. Epub 2018 Nov 28. Ann Rheum Dis. 2020. PMID: 30487148 No abstract available.
-
Can we prescribe TMP/SMX prophylaxis without any concerns equally for all patients with rheumatic disease?Ann Rheum Dis. 2019 Feb;78(2):e17. doi: 10.1136/annrheumdis-2018-213027. Epub 2018 Feb 6. Ann Rheum Dis. 2019. PMID: 29437584 No abstract available.
-
Methotrexate and trimethoprim-sulfamethoxazole for Pneumocystis pneumonia prophylaxis.J Rheumatol. 2011 Apr;38(4):777; author reply 778. doi: 10.3899/jrheum.100858. J Rheumatol. 2011. PMID: 21459958 No abstract available.
-
Pneumocystis carinii pneumonia in rheumatoid arthritis patients treated with methotrexate. A report of two cases.Rev Rhum Engl Ed. 1996 Jun;63(6):453-6. Rev Rhum Engl Ed. 1996. PMID: 8817757 Review.
-
Pneumocystis carinii pneumonia associated with methotrexate therapy in rheumatoid arthritis.J Rheumatol. 1991 Aug;18(8):1254-6. J Rheumatol. 1991. PMID: 1941836 Review.
Cited by
-
Pneumocystis jirovecii Pneumonia Prophylaxis in Patients with ANCA Vasculitis on Rituximab Maintenance Therapy.Glomerular Dis. 2024 Jul 26;4(1):152-158. doi: 10.1159/000539993. eCollection 2024 Jan-Dec. Glomerular Dis. 2024. PMID: 39144477 Free PMC article.
-
[Influence of underlying disease and immunosuppression on the immunocompetence in inflammatory rheumatic diseases].Z Rheumatol. 2024 Mar;83(2):87-97. doi: 10.1007/s00393-023-01408-4. Epub 2023 Aug 29. Z Rheumatol. 2024. PMID: 37644129 Review. German.
-
Position statement on infection screening, prophylaxis, and vaccination in pediatric patients with rheumatic diseases and immunosuppressive therapies, part 2: infection prophylaxis.Eur J Pediatr. 2023 Sep;182(9):4271-4284. doi: 10.1007/s00431-023-05080-3. Epub 2023 Jul 13. Eur J Pediatr. 2023. PMID: 37439850 Free PMC article. Review.
-
Duration of prednisone treatment before development of Pneumocystis jirovecii pneumonia in patients with vasculitis: A case series.J Assoc Med Microbiol Infect Dis Can. 2022 Jun 3;7(2):117-124. doi: 10.3138/jammi-2021-0031. eCollection 2022 Jun. J Assoc Med Microbiol Infect Dis Can. 2022. PMID: 36337351 Free PMC article.
-
Rates of Pneumocystis jirovecii pneumonia and prophylaxis prescribing patterns in a large electronic health record cohort of patients with systemic lupus erythematosus.Semin Arthritis Rheum. 2022 Dec;57:152106. doi: 10.1016/j.semarthrit.2022.152106. Epub 2022 Oct 17. Semin Arthritis Rheum. 2022. PMID: 36279805 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
